Rutledge Leads States in Amicus Brief in Execution Drug Case
August 7, 2018
Says, ‘The families of these victims deserve justice’
LITTLE ROCK – Arkansas Attorney General Leslie Rutledge led a coalition of fifteen states in filing an amicus brief in support of the State of Nevada, arguing the lawsuits continuing to be brought by pharmaceutical companies in order to prevent their drugs from being used to carry out the lawful sentences of execution are meritless.
“The families of these victims deserve justice,” said Attorney General Rutledge. “The pharmaceutical companies, such as McKesson and Alvogen, are being pressured by anti-death-penalty advocates to stop supplying the drug to carry out lawful executions. Just as the Arkansas Supreme Court did not rule in favor of these pressure tactics, neither should the Nevada Supreme Court.”
“Lawsuits like McKesson’s or Alvogen’s do not even need to succeed on the merits in order to achieve the desired outcome and prevent an execution. Instead, they merely have to obtain an injunction preventing a state from carrying out an execution on the scheduled date. And that alone might delay an execution long enough that a state’s drugs could expire,” said the states in the brief.
Arkansas is joined in the amicus brief by Alabama, Arizona, Florida, Georgia, Idaho, Indiana, Louisiana, Missouri, Nebraska, Oklahoma, South Carolina, Tennessee, Texas and Utah.